These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 18718031)

  • 1. Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms.
    George-Chandy A; Trysberg E; Eriksson K
    Arthritis Res Ther; 2008; 10(4):R97. PubMed ID: 18718031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid levels of a proliferation-inducing ligand (APRIL) are increased in patients with neuropsychiatric systemic lupus erythematosus.
    Hopia L; Thangarajh M; Khademi M; Laveskog A; Wallström E; Svenungsson E; Andersson M
    Scand J Rheumatol; 2011; 40(5):363-72. PubMed ID: 21585290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of serum B cell activating factor from the tumour necrosis factor family (BAFF) and a proliferation-inducing ligand (APRIL) with central nervous system and renal disease in systemic lupus erythematosus.
    Vincent FB; Northcott M; Hoi A; Mackay F; Morand EF
    Lupus; 2013 Aug; 22(9):873-84. PubMed ID: 23846230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of TWEAK to assess neuropsychiatric disease activity in systemic lupus erhytematosus.
    Fragoso-Loyo H; Atisha-Fregoso Y; Nuñez-Alvarez CA; Llorente L
    Lupus; 2016 Apr; 25(4):364-9. PubMed ID: 26466614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APRIL levels strongly correlate with IL-17 in systemic lupus erythematosus.
    Eilertsen GØ; Nossent JC
    Lupus; 2014 Nov; 23(13):1383-91. PubMed ID: 25057039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
    Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
    Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The heterogeneity of neuropsychiatric systemic lupus erythematosus is reflected in lack of association with cerebrospinal fluid cytokine profiles.
    Jönsen A; Bengtsson AA; Nived O; Ryberg B; Truedsson L; Rönnblom L; Alm GV; Sturfelt G
    Lupus; 2003; 12(11):846-50. PubMed ID: 14667101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-6, IL-8, IP-10, MCP-1 and G-CSF are significantly increased in cerebrospinal fluid but not in sera of patients with central neuropsychiatric lupus erythematosus.
    Yoshio T; Okamoto H; Kurasawa K; Dei Y; Hirohata S; Minota S
    Lupus; 2016 Aug; 25(9):997-1003. PubMed ID: 26846690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation Between B-Cell Activating Factor of the Tumor Necrosis Factor Family Level in Serum and Immune Inflammation in Patients with Neuropsychiatric Systemic Lupus Erythematosus and its Clinical Value.
    Pang J; Li Y; Tao R; Li J; Wang F; Xu H
    Immunol Invest; 2024 May; 53(4):559-573. PubMed ID: 38329469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement.
    Trysberg E; Carlsten H; Tarkowski A
    Lupus; 2000; 9(7):498-503. PubMed ID: 11035414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of blood-brain barrier function by quotient alpha2 macroglobulin and its relationship with interleukin-6 and complement component 3 levels in neuropsychiatric systemic lupus erythematosus.
    Asano T; Ito H; Kariya Y; Hoshi K; Yoshihara A; Ugawa Y; Sekine H; Hirohata S; Yamaguchi Y; Sato S; Kobayashi H; Migita K; Ohira H; Hashimoto Y; Watanabe H
    PLoS One; 2017; 12(10):e0186414. PubMed ID: 29036223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus.
    Salazar-Camarena DC; Ortiz-Lazareno PC; Cruz A; Oregon-Romero E; Machado-Contreras JR; Muñoz-Valle JF; Orozco-López M; Marín-Rosales M; Palafox-Sánchez CA
    Lupus; 2016 May; 25(6):582-92. PubMed ID: 26424128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis.
    Vallerskog T; Heimbürger M; Gunnarsson I; Zhou W; Wahren-Herlenius M; Trollmo C; Malmström V
    Arthritis Res Ther; 2006; 8(6):R167. PubMed ID: 17092341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.
    Fragoso-Loyo H; Cabiedes J; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Diamond B; Llorente L; Sánchez-Guerrero J
    PLoS One; 2008 Oct; 3(10):e3347. PubMed ID: 18836530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus.
    Kwieciński J; Kłak M; Trysberg E; Blennow K; Tarkowski A; Jin T
    Arthritis Rheum; 2009 Jul; 60(7):2094-101. PubMed ID: 19565516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
    Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
    Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expressions of BAFF/BAFF receptors and their correlation with disease activity in Chinese SLE patients.
    Zhao LD; Li Y; Smith MF; Wang JS; Zhang W; Tang FL; Tian XP; Wang HY; Zhang FC; Ba DN; He W; Zhang X
    Lupus; 2010 Nov; 19(13):1534-49. PubMed ID: 20974656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood-brain barrier damages and intrathecal synthesis of anti-N-methyl-D-aspartate receptor NR2 antibodies in diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus.
    Hirohata S; Arinuma Y; Yanagida T; Yoshio T
    Arthritis Res Ther; 2014 Mar; 16(2):R77. PubMed ID: 24655341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of interferon-α as a biomarker in central neuropsychiatric involvement in systemic lupus erythematosus.
    Fragoso-Loyo H; Atisha-Fregoso Y; Núñez-Alvarez CA; Llorente L; Sánchez-Guerrero J
    J Rheumatol; 2012 Mar; 39(3):504-9. PubMed ID: 22247358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of cerebrospinal fluid anti-Sm antibodies with acute confusional state in systemic lupus erythematosus.
    Hirohata S; Sakuma Y; Yanagida T; Yoshio T
    Arthritis Res Ther; 2014 Oct; 16(5):450. PubMed ID: 25273532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.